Kagarmanova, Ainur
Sparkman, Heather
Laiteerapong, Neda
Thompson, Katherine
Rosul, Linda
Lazar, Danielle
Staab, Erin
Wan, Wen
Kass, Amanda
Ari, Mim http://orcid.org/0000-0001-8410-4090
Funding for this research was provided by:
Agency for Healthcare Research and Quality (1R18HS027910-01)
Article History
Received: 22 March 2022
Accepted: 11 July 2022
First Online: 27 July 2022
Declarations
:
: The study was approved by the University of Chicago Biological Sciences Division Institutional Review Board, protocol number IRB2-1580. The study is registered at ClinicalTrials.gov under #NCT04878562. For ECHO-Chicago, a local version of Project ECHO®, participants, a consent script cover page will be included with the online surveys that PCPs complete before and after the course. Informed consent waiver for patients was obtained because I-COPE does not provide clinical recommendations different from the standard of care. The study team will receive a de-identified dataset from the Center for Research Informatics at the University of Chicago, so the collection and storage of data do not put patients’ confidentiality at risk. A Data and Safety Monitoring Board (DSMB) was formed to protect the safety of study subjects and assure that the quality of the research data generated is acceptable. The DSMB will convene every 6 months for the duration of the program’s implementation to assess the progress of the study, participant safety, quality of data management, and analysis. All unanticipated problems will be reported to the PIs who will report the problem to the IRB. All authors are given access to the final study datasets; the datasets will be stored on the University of Chicago Box application that requires two-factor authentication.
: All authors approved the final manuscript.
: The authors declared that they have no competing interests.